Authors:
Steels, E
Paesmans, B
Berghmans, T
Branle, F
Lemaitre, F
Mascaux, C
Meert, AP
Vallot, F
Lafitte, JJ
Sculier, JP
Citation: E. Steels et al., Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis, EUR RESP J, 18(4), 2001, pp. 705-719
Authors:
Miotto, D
Christodoulopoulos, P
Olivenstein, R
Taha, R
Cameron, L
Tsicopoulos, A
Tonnel, AB
Fahy, O
Lafitte, JJ
Luster, AD
Wallaert, B
Mapp, CE
Hamid, Q
Citation: D. Miotto et al., Expression of IFN-gamma-inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in T(H)1-and T(H)2-mediated lung diseases, J ALLERG CL, 107(4), 2001, pp. 664-670
Authors:
Sculier, JP
Ghisdal, L
Berghmans, T
Branle, F
Lafitte, JJ
Vallot, F
Meert, AP
Lemaitre, F
Steels, E
Burniat, A
Mascaux, C
Paesmans, M
Citation: Jp. Sculier et al., The role of mitomycin in the treatment of non small cell lung cancer: a systematic review with meta-analysis of the literature, BR J CANC, 84(9), 2001, pp. 1150-1155
Authors:
Guichard, C
Harricane, MC
Lafitte, JJ
Godard, P
Zaegel, M
Tack, V
Lalau, G
Bouvagnet, P
Citation: C. Guichard et al., Axonemal dynein intermediate-chain gene (DNAI1) mutations result in situs inversus and primary ciliary dyskinesia (Kartagener syndrome), AM J HU GEN, 68(4), 2001, pp. 1030-1035
Authors:
Lo-Guidice, JM
Allorge, D
Chevalier, D
Debuysere, H
Fazio, F
Lafitte, JJ
Broly, F
Citation: Jm. Lo-guidice et al., Molecular analysis of the N-acetyltransferase 1 gene (NAT1) using polymerase chain reaction-restriction fragment-single strand conformation polymorphism assay, PHARMACOGEN, 10(4), 2000, pp. 293-300
Authors:
Mascaux, C
Paesmans, M
Berghmans, T
Branle, F
Lafitte, JJ
Lemaitre, F
Meert, AP
Vermylen, P
Sculier, JP
Citation: C. Mascaux et al., A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis, LUNG CANC, 30(1), 2000, pp. 23-36
Authors:
Sculier, JP
Lafitte, JJ
Berghmans, T
Thiriaux, J
Lecomte, J
Efremidis, A
Ninane, V
Paesmans, M
Mommen, P
Klastersky, J
Citation: Jp. Sculier et al., A phase II trial testing gemcitabine as second-line chemotherapy for non small cell lung cancer, LUNG CANC, 29(1), 2000, pp. 67-73
Authors:
Shimbara, A
Christodoulopoulos, P
Soussi-Gounni, A
Olivenstein, R
Nakamura, Y
Levitt, RC
Nicolaides, NC
Holroyd, KJ
Tsicopoulos, A
Lafitte, JJ
Wallaert, B
Hamid, QA
Citation: A. Shimbara et al., IL-9 and its receptor in allergic and nonallergic lung disease: Increased expression in asthma, J ALLERG CL, 105(1), 2000, pp. 108-115
Authors:
Sculier, JP
Lafitte, JJ
Paesmans, M
Thiriaux, J
Alexopoulos, CG
Baumohl, J
Schmerber, J
Koumakis, G
Florin, MC
Zacharias, C
Berghmans, T
Mommen, P
Ninane, V
Klastersky, J
Citation: Jp. Sculier et al., Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer, BR J CANC, 83(9), 2000, pp. 1128-1135
Authors:
Hamid, QA
Wenzel, SE
Hauk, PJ
Tsicopoulos, A
Wallaert, B
Lafitte, JJ
Chrousos, GP
Szefler, SJ
Leung, DYM
Citation: Qa. Hamid et al., Increased glucocorticoid receptor beta in airway cells of glucocorticoid-insensitive asthma, AM J R CRIT, 159(5), 1999, pp. 1600-1604
Authors:
Sculier, JP
Paesmans, M
Thiriaux, J
Lecomte, J
Bureau, G
Giner, V
Koumakis, G
Lafitte, JJ
Berchier, MC
Alexopoulos, CG
Zacharias, C
Mommen, P
Ninane, V
Klastersky, J
Citation: Jp. Sculier et al., A comparison of methods of calculation for estimating carboplatin AUC witha retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer, EUR J CANC, 35(9), 1999, pp. 1314-1319
Authors:
Davril, M
Degroote, S
Humbert, P
Galabert, C
Dumur, V
Lafitte, JJ
Lamblin, G
Roussel, P
Citation: M. Davril et al., The sialylation of bronchial mucins secreted by patients suffering from cystic fibrosis or from chronic bronchitis is related to the severity of airway infection, GLYCOBIOLOG, 9(3), 1999, pp. 311-321
Authors:
Sculier, JP
Paesmans, M
Lafitte, JJ
Baumohl, J
Thiriaux, J
van Cutsem, O
Recloux, P
Bureau, G
Berchier, MC
Zacharias, C
Mommen, P
Bosschaerts, T
Berghmans, T
van Houtte, P
Ninane, V
Klastersky, J
Citation: Jp. Sculier et al., A randomised phase III trial comparing consolidation treatment with further chemotherapy to chest irradiation in patients with initially unresectablelocoregional non-small-cell lung cancer responding to induction chemotherapy, ANN ONCOL, 10(3), 1999, pp. 295-303
Authors:
Brichet, A
Stach, B
Dubois, F
Pruvo, JP
Duhamel, A
Lafitte, JJ
Citation: A. Brichet et al., Neurological examination and brain computed tomography in the initial staging of non-small-cell lung cancer (NSCLC): a prospective study., REV MAL RES, 16(3), 1999, pp. 361-368
Authors:
Sculier, JP
Paesmans, M
Ninane, V
Giner, V
Bureau, G
Lafitte, JJ
Baumohl, J
Thiriaux, J
van Cutsem, O
Recloux, P
Berchier, MC
Zacharias, C
Mommen, P
van Houtte, P
Klastersky, J
Citation: Jp. Sculier et al., Evaluation of the TN sub-staging in patients with initially unresectable stage III non-small cell lung cancer treated by induction chemotherapy, LUNG CANC, 22(3), 1998, pp. 201-213